Executive Committee: Akeso, Inc.

Manager
Positions heldSince
Michelle Xia

Michelle Xia

59 year

Chief Executive Officer 19/03/2012
Founder 19/03/2012
President 19/03/2012
Baiyong Li

Baiyong Li

58 year

Chief Tech/Sci/R&D Officer 16/11/2019
Founder 19/03/2012
Wai Yan Leung

Wai Yan Leung

Corporate Secretary 23/08/2022
Bing Wang

Bing Wang

49 year

Director of Finance/CFO 22/07/2024

Composition of the Board of Directors: Akeso, Inc.

Director
CommitteesSince
Michelle Xia

Michelle Xia

59 year

Compensation Committee 16/11/2019
Nominating Committee Chair 16/11/2019
Peng Zhang

Peng Zhang

50 year

Audit Committee 18/04/2022
Compensation Committee 18/04/2022
Nominating Committee 01/09/2025
Compensation Committee Chair 01/12/2025
Yan Xu

Yan Xu

63 year

Audit Committee 01/04/2020
Nominating Committee 01/04/2020
Compensation Committee Chair 01/06/2015
Compensation Committee 01/04/2020
Bo Tan

Bo Tan

53 year

Audit Committee Chair
Compensation Committee
Nominating Committee
Jun Wen Zeng

Jun Wen Zeng

64 year

Audit Committee
Nominating Committee
Compensation Committee Chair
Rong Gang Xie

Rong Gang Xie

40 year

Audit Committee 14/07/2023
Zhongmin Wang

Zhongmin Wang

57 year

Director/Board Member 16/11/2019
Baiyong Li

Baiyong Li

58 year

Director/Board Member 16/11/2019

Former Officers and Directors: Akeso, Inc.

Insider
Positions held
SinceUntil
Yu Xia
Yu Xia
Director/Board Member 01/11/2019 30/06/2024
Yi Zhou
Yi Zhou
Director/Board Member 01/11/2019 30/06/2024
Xiao Jie Xi
Xiao Jie Xi
Director of Finance/CFO 01/11/2018 03/05/2023
Corporate Secretary 16/11/2019 03/05/2023
Pui Chun Suen
Pui Chun Suen
Corporate Secretary - 23/08/2022
Hui Xin Liang
Hui Xin Liang
Corporate Secretary 23/08/2022 -
Xiao Ping Jin
Xiao Ping Jin
Corporate Officer/Principal - 01/08/2021
Pung Fei Chan
Pung Fei Chan
Corporate Secretary 16/11/2019 14/12/2020
Li Jun Lin
Li Jun Lin
Director/Board Member 01/11/2019 19/08/2020

Age distribution of managers

Parity Men Women

Male12
Female1

Of which Executive Committee

Male3
Female1

Of which Directors

Male8
Female0

Revisions

Recommandations analystes
-
Évolution recommandations analystes 1 an
-
Évolution recommandations analystes 4 mois
-
Objectif analystes
-
Évolution objectif analystes 1 an
-
Évolution objectif analystes 4 mois
-
ESG MSCI

ESG MSCI

Environnement
Social
Gouvernance
Polémique
Controverses Ethiques
No
Controverses sur les droits de l'Homme
No
Controverses Subventions fiscales
No
Conforme à la finance Islamique
No
Logo Akeso, Inc.
Akeso Inc is an investment holding company mainly engaged in the research and development, production and commercialization of biopharmaceutical products. The Company is committed to the research, development, manufacturing and commercialization of innovative antibody drugs that are affordable to patients worldwide. The Company's products mainly include cadonilimab (PD-1/CTLA-4), Ivonescimab (AK112, PD-1/VEGF), ANNIKO (penpulimab, PD-1), Ebronucimab (AK102, PCSK9) and ebdarokimab (AK101, IL-12/IL-23). The Company's products are principally used to treat tumors, autoimmune diseases, metabolic diseases, as well as neurodegenerative diseases. The Company principally conducts its businesses in Mainland China, the United States and other markets.
Employees
3,761